YN
Yigal Nochomovitz Citigroup Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
26
Shattuck Labs
STTK
$90.1M
| $2.01 | $2 |
1%
downside
| Neutral |
2 Oct ‘24
11 months ago |
|
27
IDEAYA Biosciences
IDYA
$2.05B
| $24.74 | $58 |
134%
upside
| Buy |
27 Aug ‘24
1 year ago |
|
28
MacroGenics
MGNX
$111M
| $1.73 | $14 |
709%
upside
| Buy |
15 Aug ‘24
1 year ago |
|
|
ONC
29
BeOne Medicines Ltd. American Depositary Shares
ONC
$38.1B
| $351.13 | $288 |
18%
downside
| Buy |
8 Aug ‘24
1 year ago |
|
30
Ovid Therapeutics
OVID
$88.2M
| $1.24 | $1.20 |
3%
downside
| Neutral |
18 Jun ‘24
1 year ago |
|
31
Arcus Biosciences
RCUS
$1.22B
| $11.32 | $38 |
236%
upside
| Buy |
3 Jun ‘24
1 year ago |
|
32
Oric Pharmaceuticals
ORIC
$1.02B
| $10.91 | $14 |
28%
upside
| Buy |
7 May ‘24
1 year ago |
|
33
ProQR Therapeutics
PRQR
$245M
| $2.33 | $2 |
14%
downside
| Neutral |
18 Apr ‘24
1 year ago |
|
34
Aldeyra Therapeutics
ALDX
$342M
| $5.76 | $8 |
39%
upside
| Buy |
17 Oct ‘23
1 year ago |
|
35
Atara Biotherapeutics
ATRA
$85.5M
| $11.95 | $35 |
193%
upside
| Sell |
21 Aug ‘23
2 years ago |
|
36
Ultragenyx Pharmaceutical
RARE
$3.04B
| $31.50 | $133 |
322%
upside
| Buy |
7 Jun ‘23
2 years ago |
|
|
CLLS
37
Cellectis
CLLS
$275M
| $2.85 | $16 |
461%
upside
| Buy |
5 Apr ‘23
2 years ago |
|
38
Fate Therapeutics
FATE
$111M
| $0.9799 | $10 |
921%
upside
| Buy |
2 Mar ‘23
2 years ago |
|
|
IPHA
39
Innate Pharma
IPHA
$188M
| $2.04 | $12 |
488%
upside
| Buy |
16 Sep ‘22
3 years ago |
|